Diabetes and cancer: A consensus report
In this trial, the oxidative stress in patients with CAD has been reduced significantly by L-carnitine administered at a dose of 1000 mg/d for 12 weeks with the increase in the activities of antioxidant enzymes
Hy vng bn c gii p c glutathione c tc dng g vi da, cng nh lu khi s dng cht ny m bo sc khe ln da
Orlistat, phentermine/topiramate, naltrexone/bupropion, and the incretin-based drugs liraglutide and semaglutide, both GLP-1 receptor agonists (GLP-1RA), and tirzepatide, a biased dual GIP/GLP-1 receptor agonist, are currently both FDA and EMA approved for the management of non-syndromic obesity 10
But beneath the surface of glossy marketing and fitness fantasies lies a far more sobering truth: many of these substances operate in a medical grey zone, with unknown long-term risks, questionable manufacturing standards, and in some cases, life-threatening side-effects